Ubs Asset Management Americas Inc Guardant Health, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,933,988 shares of GH stock, worth $162 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,933,988
Previous 2,777,040
5.65%
Holding current value
$162 Million
Previous $118 Million
29.06%
% of portfolio
0.03%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding GH
# of Institutions
415Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...